Soy phosphatidylglycerol reduces inflammation in a contact irritant ear edema mouse model in vivo

Ding Xie, Vivek Choudhary, Mutsa Seremwe, John G. Edwards, Angela Wang, Aaron C. Emmons, Katherine A. Bollag, Maribeth H Johnson, Wendy B Bollag

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We have previously shown that phosphatidylglycerol (PG) regulates the function of keratinocytes, the predominant cells that compose the epidermis, inhibiting the proliferation of rapidly dividing keratinocytes. In particular, soy PG, a PG mixture with a high proportion of polyunsaturated fatty acids, is efficacious at inhibiting these proliferating keratinocytes. Psoriasis is a skin disorder characterized by hyperproliferation of keratinocytes and inflammation. Data in the lung suggest that PG in pulmonary surfactant inhibits inflammation. To investigate the possibility of using PG containing polyunsaturated fatty acids for the treatment of psoriasis, we examined the effect of soy PG on inflammation induced by the application of 12-O-tetradecanoylphorbol 13-acetate (TPA), a contact irritant, to mouse ears in vivo. We monitored ear thickness and weight as a measure of ear edema, as well as CD45-positive immune cell infiltration. Our results indicate that soy PG when applied together with 1,25-dihydroxyvitamin D 3 (vitamin D), an agent known to acutely disrupt the skin barrier, suppressed ear edema and inhibited the infiltration of CD45-positive immune cells. On the other hand, neither PG nor vitamin D alone was effective. The combination also decreased tumor necrosis factor-a (TNFa) levels. This result suggested the possibility that PG was not permeating the skin barrier efficiently. Therefore, in a further study we applied PG in a penetration-enhancing vehicle and found that it inhibited inflammation induced by the phorbol ester and decreased CD45-positive immune cell infiltration. Our results suggest the possibility of using soy PG as a topical treatment option for psoriasis.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume366
Issue number1
DOIs
StatePublished - Jul 1 2018

Fingerprint

Phosphatidylglycerols
Irritants
Ear
Edema
Inflammation
Keratinocytes
Psoriasis
Unsaturated Fatty Acids
Skin
Pulmonary Surfactants
Cholecalciferol
Phorbol Esters
Tetradecanoylphorbol Acetate
Epidermis
Vitamin D
Tumor Necrosis Factor-alpha

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Soy phosphatidylglycerol reduces inflammation in a contact irritant ear edema mouse model in vivo. / Xie, Ding; Choudhary, Vivek; Seremwe, Mutsa; Edwards, John G.; Wang, Angela; Emmons, Aaron C.; Bollag, Katherine A.; Johnson, Maribeth H; Bollag, Wendy B.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 366, No. 1, 01.07.2018, p. 1-8.

Research output: Contribution to journalArticle

@article{acbb61efcb9f4e868460ee324d7ded6e,
title = "Soy phosphatidylglycerol reduces inflammation in a contact irritant ear edema mouse model in vivo",
abstract = "We have previously shown that phosphatidylglycerol (PG) regulates the function of keratinocytes, the predominant cells that compose the epidermis, inhibiting the proliferation of rapidly dividing keratinocytes. In particular, soy PG, a PG mixture with a high proportion of polyunsaturated fatty acids, is efficacious at inhibiting these proliferating keratinocytes. Psoriasis is a skin disorder characterized by hyperproliferation of keratinocytes and inflammation. Data in the lung suggest that PG in pulmonary surfactant inhibits inflammation. To investigate the possibility of using PG containing polyunsaturated fatty acids for the treatment of psoriasis, we examined the effect of soy PG on inflammation induced by the application of 12-O-tetradecanoylphorbol 13-acetate (TPA), a contact irritant, to mouse ears in vivo. We monitored ear thickness and weight as a measure of ear edema, as well as CD45-positive immune cell infiltration. Our results indicate that soy PG when applied together with 1,25-dihydroxyvitamin D 3 (vitamin D), an agent known to acutely disrupt the skin barrier, suppressed ear edema and inhibited the infiltration of CD45-positive immune cells. On the other hand, neither PG nor vitamin D alone was effective. The combination also decreased tumor necrosis factor-a (TNFa) levels. This result suggested the possibility that PG was not permeating the skin barrier efficiently. Therefore, in a further study we applied PG in a penetration-enhancing vehicle and found that it inhibited inflammation induced by the phorbol ester and decreased CD45-positive immune cell infiltration. Our results suggest the possibility of using soy PG as a topical treatment option for psoriasis.",
author = "Ding Xie and Vivek Choudhary and Mutsa Seremwe and Edwards, {John G.} and Angela Wang and Emmons, {Aaron C.} and Bollag, {Katherine A.} and Johnson, {Maribeth H} and Bollag, {Wendy B}",
year = "2018",
month = "7",
day = "1",
doi = "10.1124/jpet.117.244756",
language = "English (US)",
volume = "366",
pages = "1--8",
journal = "The Journal of pharmacology and experimental therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Soy phosphatidylglycerol reduces inflammation in a contact irritant ear edema mouse model in vivo

AU - Xie, Ding

AU - Choudhary, Vivek

AU - Seremwe, Mutsa

AU - Edwards, John G.

AU - Wang, Angela

AU - Emmons, Aaron C.

AU - Bollag, Katherine A.

AU - Johnson, Maribeth H

AU - Bollag, Wendy B

PY - 2018/7/1

Y1 - 2018/7/1

N2 - We have previously shown that phosphatidylglycerol (PG) regulates the function of keratinocytes, the predominant cells that compose the epidermis, inhibiting the proliferation of rapidly dividing keratinocytes. In particular, soy PG, a PG mixture with a high proportion of polyunsaturated fatty acids, is efficacious at inhibiting these proliferating keratinocytes. Psoriasis is a skin disorder characterized by hyperproliferation of keratinocytes and inflammation. Data in the lung suggest that PG in pulmonary surfactant inhibits inflammation. To investigate the possibility of using PG containing polyunsaturated fatty acids for the treatment of psoriasis, we examined the effect of soy PG on inflammation induced by the application of 12-O-tetradecanoylphorbol 13-acetate (TPA), a contact irritant, to mouse ears in vivo. We monitored ear thickness and weight as a measure of ear edema, as well as CD45-positive immune cell infiltration. Our results indicate that soy PG when applied together with 1,25-dihydroxyvitamin D 3 (vitamin D), an agent known to acutely disrupt the skin barrier, suppressed ear edema and inhibited the infiltration of CD45-positive immune cells. On the other hand, neither PG nor vitamin D alone was effective. The combination also decreased tumor necrosis factor-a (TNFa) levels. This result suggested the possibility that PG was not permeating the skin barrier efficiently. Therefore, in a further study we applied PG in a penetration-enhancing vehicle and found that it inhibited inflammation induced by the phorbol ester and decreased CD45-positive immune cell infiltration. Our results suggest the possibility of using soy PG as a topical treatment option for psoriasis.

AB - We have previously shown that phosphatidylglycerol (PG) regulates the function of keratinocytes, the predominant cells that compose the epidermis, inhibiting the proliferation of rapidly dividing keratinocytes. In particular, soy PG, a PG mixture with a high proportion of polyunsaturated fatty acids, is efficacious at inhibiting these proliferating keratinocytes. Psoriasis is a skin disorder characterized by hyperproliferation of keratinocytes and inflammation. Data in the lung suggest that PG in pulmonary surfactant inhibits inflammation. To investigate the possibility of using PG containing polyunsaturated fatty acids for the treatment of psoriasis, we examined the effect of soy PG on inflammation induced by the application of 12-O-tetradecanoylphorbol 13-acetate (TPA), a contact irritant, to mouse ears in vivo. We monitored ear thickness and weight as a measure of ear edema, as well as CD45-positive immune cell infiltration. Our results indicate that soy PG when applied together with 1,25-dihydroxyvitamin D 3 (vitamin D), an agent known to acutely disrupt the skin barrier, suppressed ear edema and inhibited the infiltration of CD45-positive immune cells. On the other hand, neither PG nor vitamin D alone was effective. The combination also decreased tumor necrosis factor-a (TNFa) levels. This result suggested the possibility that PG was not permeating the skin barrier efficiently. Therefore, in a further study we applied PG in a penetration-enhancing vehicle and found that it inhibited inflammation induced by the phorbol ester and decreased CD45-positive immune cell infiltration. Our results suggest the possibility of using soy PG as a topical treatment option for psoriasis.

UR - http://www.scopus.com/inward/record.url?scp=85059822656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059822656&partnerID=8YFLogxK

U2 - 10.1124/jpet.117.244756

DO - 10.1124/jpet.117.244756

M3 - Article

AN - SCOPUS:85059822656

VL - 366

SP - 1

EP - 8

JO - The Journal of pharmacology and experimental therapeutics

JF - The Journal of pharmacology and experimental therapeutics

SN - 0022-3565

IS - 1

ER -